EVALUATION SYSTEM FOR EVALUATING PSORIASIS AND USE THEREOF

The invention belongs to the field of medical information technology, and specifically relates to an evaluation system for evaluating psoriasis and use thereof. The evaluation system includes: a data acquisition module for acquiring the dsDNA content of a serum sample to be detected, a data analysis module for evaluating psoriasis based on the dsDNA content, and a data output module for outputting results according to the evaluated psoriasis. When the serum sample to be detected is a serum sample without phenotype and the dsDNA content is greater than or equal to 1.11 ng/ml, the output would be: abnormal and extremely high risk. The sensitivity of the evaluation system is 61.6 percent and the specificity is 74.8 percent. Compared with other types of psoriasis-related methods and apparatuses, the sensitivity and specificity have obvious advantages.